The objective of this career development award is to provide Dr. Sharon Giordano with the experience and knowledge necessary to become an independent health services researcher in the field of breast cancer. Dr. Giordano, who is a medical oncologist and MPH candidate, will accomplish this goal through a combination of directed reading, seminars, coursework, and mentored research. A highly qualified team of mentors will supervise her training and ensure that she meets her goals. Dr. Giordano will be examining adherence to a standard course of adjuvant treatment among older women with breast cancer using two different approaches: secondary data analyses using the SEER-Medicare database and primary data collection.
The specific aims of this proposal are: 1 ) to describe lack of adherence to chemotherapy and radiotherapy in a population-based sample of older women with breast cancer; 2) to determine the effect of specific comorbidities as well as patient, physician, and environmental characteristics on adherence to chemotherapy and radiotherapy; and 3) to prospectively identify factors, including the potentially unrecognized comorbidities of depression and dementia, that affect adherence to therapy in older women with breast cancer. The first two specific aims will be accomplished using the population-based SEER-Medicare database, and the third specific aim through a prospective study. The proposed research will provide important knowledge regarding the patterns and predictors of adherence to adjuvant therapy among older women. In addition, these studies will provide the applicant with expertise in the use of cancer registry data and claims data, in primary data collection, and in data analysis. The proposed studies and career development activities will provide the applicant with the skills to develop into an independent investigator.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Academic/Teacher Award (ATA) (K07)
Project #
Application #
Study Section
Subcommittee G - Education (NCI)
Program Officer
Gorelic, Lester S
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Texas MD Anderson Cancer Center
Internal Medicine/Medicine
Other Domestic Higher Education
United States
Zip Code
Jiralerspong, S; Kim, E S; Dong, W et al. (2013) Obesity, diabetes, and survival outcomes in a large cohort of early-stage breast cancer patients. Ann Oncol 24:2506-14
Barcenas, Carlos H; Zhang, Ning; Zhao, Hui et al. (2012) Anthracycline regimen adherence in older patients with early breast cancer. Oncologist 17:303-11
Chavez-MacGregor, Mariana; Zhao, Hui; Fang, Shenying et al. (2011) Complications associated with erythropoietin-stimulating agents in patients with metastatic breast cancer: a Surveillance, Epidemiology, and End Results-Medicare study. Cancer 117:3641-9
Chavez-MacGregor, M; Zhao, H; Kroll, M et al. (2011) Risk factors and incidence of thromboembolic events (TEEs) in older men and women with breast cancer. Ann Oncol 22:2394-402
Dawood, S; Broglio, K; Ensor, J et al. (2010) Survival differences among women with de novo stage IV and relapsed breast cancer. Ann Oncol 21:2169-74
Dawood, Shaheenah; Broglio, Kristine; Buzdar, Aman U et al. (2010) Prognosis of women with metastatic breast cancer by HER2 status and trastuzumab treatment: an institutional-based review. J Clin Oncol 28:92-8
Srokowski, Tomasz P; Fang, Shenying; Hortobagyi, Gabriel N et al. (2009) Impact of diabetes mellitus on complications and outcomes of adjuvant chemotherapy in older patients with breast cancer. J Clin Oncol 27:2170-6
Dawood, Shaheenah; Broglio, Kristine; Gonzalez-Angulo, Ana M et al. (2008) Trends in survival over the past two decades among white and black patients with newly diagnosed stage IV breast cancer. J Clin Oncol 26:4891-8
Srokowski, Tomasz P; Fang, Shenying; Duan, Zhigang et al. (2008) Completion of adjuvant radiation therapy among women with breast cancer. Cancer 113:22-9
Giordano, Sharon H; Kuo, Yong-Fang; Duan, Zhigang et al. (2008) Limits of observational data in determining outcomes from cancer therapy. Cancer 112:2456-66

Showing the most recent 10 out of 23 publications